Matches in SemOpenAlex for { <https://semopenalex.org/work/W81987503> ?p ?o ?g. }
- W81987503 endingPage "37" @default.
- W81987503 startingPage "429" @default.
- W81987503 abstract "To examine the effects of short-term valproate treatment on human brain serotonin and dopamine function by means of challenge tests with ipsapirone, a partial agonist at 5-HT1A receptors, and apomorphine, a dopamine receptor agonist.Experimental challenge-rechallenge, within-subjects repeated measures, before and at the end of 14 days of treatment with valproate at a dosage of 625 mg/d (reached gradually over the first 5 days).Eight healthy male volunteers (mean age 38 years) selected for good physical and mental health who were nonsmokers.Pharmacological probes were used to evaluate the effects of valproate. In the ipsapirone challenge, changes in adrenocorticotropic hormone (ACTH), cortisol and body temperature were measured, and in the apomorphine challenge, growth hormone (GH) and prolactin were the dependent variables.Valproate treatment did not significantly alter the ACTH, cortisol or body temperature responses to ipsapirone (20 mg by mouth), which reached equivalent plasma levels at each challenge. Similarly, valproate treatment did not alter the GH or prolactin responses to apomorphine (5 micrograms/kg subcutaneously).These results suggest that short-term treatment with valproate at a dose of 625 mg/d does not alter hypothalamic or pituitary 5-HT1A or dopamine receptor responses to challenges with ipsapirone and apomorphine, respectively." @default.
- W81987503 created "2016-06-24" @default.
- W81987503 creator A5017257562 @default.
- W81987503 creator A5021568220 @default.
- W81987503 creator A5022694312 @default.
- W81987503 creator A5027246988 @default.
- W81987503 creator A5034130355 @default.
- W81987503 creator A5056830972 @default.
- W81987503 creator A5068644391 @default.
- W81987503 creator A5084126830 @default.
- W81987503 date "2002-11-01" @default.
- W81987503 modified "2023-09-26" @default.
- W81987503 title "Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects." @default.
- W81987503 cites W129907205 @default.
- W81987503 cites W1780720469 @default.
- W81987503 cites W1969997807 @default.
- W81987503 cites W1971489137 @default.
- W81987503 cites W1972765670 @default.
- W81987503 cites W1974808778 @default.
- W81987503 cites W1977738924 @default.
- W81987503 cites W1988727159 @default.
- W81987503 cites W1989002189 @default.
- W81987503 cites W1993777782 @default.
- W81987503 cites W1996231894 @default.
- W81987503 cites W1997561398 @default.
- W81987503 cites W2005190740 @default.
- W81987503 cites W2005708482 @default.
- W81987503 cites W2014860907 @default.
- W81987503 cites W2016085629 @default.
- W81987503 cites W2016607699 @default.
- W81987503 cites W2017385017 @default.
- W81987503 cites W2023101237 @default.
- W81987503 cites W2029746418 @default.
- W81987503 cites W2030567557 @default.
- W81987503 cites W2040314994 @default.
- W81987503 cites W2042440825 @default.
- W81987503 cites W2045926687 @default.
- W81987503 cites W2054495934 @default.
- W81987503 cites W2060417500 @default.
- W81987503 cites W2060629478 @default.
- W81987503 cites W2065660066 @default.
- W81987503 cites W2066627514 @default.
- W81987503 cites W2066806129 @default.
- W81987503 cites W2067495470 @default.
- W81987503 cites W2067737982 @default.
- W81987503 cites W2073185149 @default.
- W81987503 cites W2077343282 @default.
- W81987503 cites W2081490747 @default.
- W81987503 cites W2083567291 @default.
- W81987503 cites W2087178211 @default.
- W81987503 cites W2091310160 @default.
- W81987503 cites W2102308762 @default.
- W81987503 cites W2117556837 @default.
- W81987503 cites W2121551654 @default.
- W81987503 cites W2129969030 @default.
- W81987503 cites W2130040176 @default.
- W81987503 cites W2143438415 @default.
- W81987503 cites W2155313713 @default.
- W81987503 cites W2156695733 @default.
- W81987503 cites W2191081153 @default.
- W81987503 cites W2331409884 @default.
- W81987503 cites W2408198940 @default.
- W81987503 cites W2737966001 @default.
- W81987503 cites W3171418018 @default.
- W81987503 cites W4237903157 @default.
- W81987503 cites W2089543072 @default.
- W81987503 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/161716" @default.
- W81987503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12491576" @default.
- W81987503 hasPublicationYear "2002" @default.
- W81987503 type Work @default.
- W81987503 sameAs 81987503 @default.
- W81987503 citedByCount "4" @default.
- W81987503 countsByYear W819875032013 @default.
- W81987503 countsByYear W819875032014 @default.
- W81987503 countsByYear W819875032016 @default.
- W81987503 crossrefType "journal-article" @default.
- W81987503 hasAuthorship W81987503A5017257562 @default.
- W81987503 hasAuthorship W81987503A5021568220 @default.
- W81987503 hasAuthorship W81987503A5022694312 @default.
- W81987503 hasAuthorship W81987503A5027246988 @default.
- W81987503 hasAuthorship W81987503A5034130355 @default.
- W81987503 hasAuthorship W81987503A5056830972 @default.
- W81987503 hasAuthorship W81987503A5068644391 @default.
- W81987503 hasAuthorship W81987503A5084126830 @default.
- W81987503 hasConcept C120069818 @default.
- W81987503 hasConcept C126322002 @default.
- W81987503 hasConcept C134018914 @default.
- W81987503 hasConcept C15744967 @default.
- W81987503 hasConcept C170493617 @default.
- W81987503 hasConcept C2775864247 @default.
- W81987503 hasConcept C2776856834 @default.
- W81987503 hasConcept C2777525119 @default.
- W81987503 hasConcept C2778258207 @default.
- W81987503 hasConcept C2778362415 @default.
- W81987503 hasConcept C2778938600 @default.
- W81987503 hasConcept C2779064019 @default.
- W81987503 hasConcept C2780546910 @default.
- W81987503 hasConcept C513476851 @default.